Opinion · United States Court of Appeals for the Federal Circuit

IN RE CYCLOBENZAPRINE HYDROCHLORIDE, 424 Fed.Appx. 952 (Fed. Cir. 2011)

In re CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENTLITIGATION. Eurand, Inc., Cephalon, Inc., & Anesta AG,Plaintiffs-Appellees, v. Mylan Pharms. Inc. & Mylan Inc.,Defendants-Appellants., 424 F. App'x 952 (Fed. Cir. 2011)

Type
Opinion
Court
United States Court of Appeals for the Federal Circuit
Jurisdiction
Federal
Date
2011-05-25
Topic
general

IN RE CYCLOBENZAPRINE HYDROCHLORIDE, 424 Fed.Appx. 952 (Fed. Cir. 2011) In re CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENTLITIGATION. Eurand, Inc., Cephalon, Inc., and Anesta AG,Plaintiffs-Appellees, v. Mylan Pharmaceuticals Inc. and Mylan Inc.,Defendants-Appellants. No. 2011-1399.United States Court of Appeals, Federal Circuit.

Citator

UpLaw has not yet analyzed IN RE CYCLOBENZAPRINE HYDROCHLORIDE, 424 Fed.Appx. 952 (Fed. Cir. 2011). The absence of a flag is not a finding that it is good law.